Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

PPD buys BioDuro to get bigger in China

December 1, 2009 Research and Development CRO, China, em

Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …
News

Building value – is the pipeline all that matters?

December 1, 2009 Research and Development Les Rose, biotech, venture capital

Venture capital is a curious business and the global financial crisis in which we find ourselves has exposed some rather …
Feature

Incyte’s Novartis cancer drug deal could be worth $1bn

December 1, 2009 Research and Development Incyte, Novartis

Novartis has paid Incyte Corporation $150 million up front for the rights to two oral investigational hematology-oncology therapies.The first is …
News
ExonHit-Therapeutics-Herve100

Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics

December 1, 2009 Research and Development ExonHit Therapeutics, appointment, research and development

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …
Appointment

GSK licences smoking vaccine candidate

November 30, 2009 Research and Development GSK, Nabi, smoking, vaccines

GlaxoSmithKline Biologicals has signed a licensing agreement for a nicotine vaccine candidate currently in the first of two phase III …
News

Clinical research news in brief

November 30, 2009 Research and Development CRO, Clinipace, ICON, Parexel

Pharmafocus’ latest round-up of clinical research news includes a new US registry to aid patient recruitment, alliances for ICON, Parexel …
News

EMA: Aligning regulation with the lifecycle of medicines

November 30, 2009 Research and Development EMA, EMEA, Thomas Lönngren, regulatory affairs

The European Agency for the Evaluation of Medicinal Products was set up in 1995 in London’s Docklands, an isolated eastern …
Feature

Roche invests in Spanish genome project

November 27, 2009 Research and Development Roche, Spain, genomics

Roche is investing in a Spanish health authority programme to analyse the genomes of people with rare diseases.The pharma company …
News

Pfizer UK’s Zubair Hussain appointed president-elect of TOPRA

November 27, 2009 Research and Development, Sales and Marketing Zubair Hussain, appointment, appointments, research and development, sales and marketing, topra

Pfizer UK’s Zubair Hussain has been appointed president-elect of global regulatory affairs organisation TOPRA.
Appointment

Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories

November 27, 2009 Research and Development AstraZeneca, appointment, appt, lilly, research and development

Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …
Appointment
MerckKgAaHQ

Merck Serono opens Beijing R&D centre

November 24, 2009 Research and Development China, Merck Serono, em

 China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …
News
logo

Sanofi expands antibody venture with Regeneron

November 12, 2009 Research and Development Regeneron, Sanofi

 Sanofi-Aventis has put more financial muscle behind its partnership with Regeneron for the development of monoclonal antibody-based drugs, boosting its …
News

Pfizer’s new RA treatment shows promise

November 11, 2009 Research and Development, Sales and Marketing Pfizer, RA

 Pfizer has announced data from two clinical studies of its developmental rheumatoid arthritis candidate.CP-690550 is the first in a new …
News

Quintiles gets bigger in Singapore

November 10, 2009 Research and Development CRO

Contract research organisation Quintiles is planning to expand its workforce in Singapore to more than 500 employees "to accommodate increased …
News

Newly-merged Pfizer unveils streamlined R&D operations

November 10, 2009 Research and Development Pfizer, restructure

 Pfizer is to close six research sites in the US and two in the UK to create its new streamlined …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026